Antileishmanial activity of selected compounds in dogs experimentally infected with Leishmania donovani.
D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D007891:Leishmania / Q000187:drug effects*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008099:Liver / Q000469:parasitology; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014677:Pharmaceutical Vehicles; D013012:Sorbitol / Q000031:analogs & derivatives*; D013154:Spleen / Q000469:parasitology
D000634:Aminoquinolines; D014677:Pharmaceutical Vehicles; D013012:Sorbitol; D008536:Meglumine